SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending due to intense speculation surrounding the upcoming Phase 3 REGAL trial results and ongoing volatility driven by a high short interest position. Community discourse remains deeply polarized, with bulls highlighting the potential for a transformative breakthrough in AML treatment and buyout rumors, while bears express significant skepticism over trial design and the company's long-term sustainability.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is drawing intense community focus as traders speculate on potential short-squeeze dynamics and the possibility of a return to higher price levels. While some participants are actively accumulating in hopes of a rapid rally, others remain cautious, debating whether recent volatility represents a genuine trend reversal or a recurring pump-and-dump cycle.

iShares Trust - iShares Expanded Tech-Software Sector ETF

iShares Expanded Tech-Software Sector ETF

The software sector is currently experiencing a strong rotation as investors pivot from crowded semiconductor momentum toward enterprise SaaS leaders. The community is actively discussing the sector's 'Agentic AI' monetization potential, debating whether this shift represents a sustainable re-rating or another temporary bounce in a volatile market environment.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

The VOO ETF is trending as investors aggressively rotate capital from broad indices into targeted semiconductor and AI memory plays amid fluctuating geopolitical tensions. The market is currently focused on navigating S&P 500 index rebalancing and high-conviction institutional rotation as traders weigh compounding long-term growth against short-term macroeconomic uncertainty.

Direxion Shares ETF Trust - Direxion Daily TSLA Bull 2X ETF

Direxion Daily TSLA Bull 2X Shares

TSLL is drawing heavy interest as traders leverage Tesla's aggressive innovation narrative and market volatility to capitalize on momentum swings. The community remains deeply divided, with some betting on a long-term rally driven by artificial intelligence and robotics, while others actively trade the leveraged decay to play both sides of the volatility.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital is garnering significant investor interest following its preliminary selection for inclusion in the Russell 3000 and Russell Microcap Indexes, with the community actively speculating on the stock's potential as it positions itself at the intersection of AI, energy, and digital infrastructure. Investors are closely monitoring potential catalysts, such as impending hyperscaler tenant announcements, while discussing the structural demand likely to be generated by index fund rebalancing.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending following the announcement of price hikes across its Mac and iPad lines, a move necessitated by soaring memory chip costs that the company can no longer absorb. Community discussions are heavily focused on the implications of these costs, debating whether this signals a broader AI-driven supply crunch or potential demand destruction as consumers face higher prices.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust is currently trending as investors debate the impact of broader market volatility and shifting institutional sentiment on Bitcoin's long-term value. Community discourse remains highly polarized, with active discussions focused on the potential for a short-term price squeeze, the significance of Bitcoin's recent testing of support levels, and varying outlooks on the role of Bitcoin ETFs in shaping the asset's future trajectory.

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is capturing market attention following FDA approval of Lumvoa for the treatment of thyroid eye disease, with the community closely tracking the company's immediate commercial launch plans and potential for market share capture. Investors are actively debating the stock's valuation, the competitive landscape against existing treatments, and the prospects for long-term growth as the firm transitions into a commercial-stage entity.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors weigh potential European regulatory outcomes against the recent implementation of key billing codes and anticipated milestone payments. The community is actively debating the company's long-term commercial strategy, management's communication, and the impact of upcoming pipeline catalysts on valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$NCNA never invest in biotech. This one is  going nowhere as it has been. No upcoming catalyst... nothing. Anyone long term is screwed due to RS.